Research status of conbercept treating age-related macular degeneration

Abstract

Age-related macular degeneration(AMD)is one of the major reasons of blindness among the elderly in the developed countries. As AMD patients are increasing year by year, AMD has become one of the important topics of ophthalmic research to prevent blindness. Its pathogenesis is not fully understood, but many studies have shown that vascular endothelial growth factor(VEGF)plays an important role in the pathogenesis. With the development and application of anti-VEGF drugs, there are a variety of drugs applied to the disease. This article introduces conbercept for the treatment of AMD.

Keywords

• anti-vascular endothelial growth factor drugs
• conbercept
• age-related macular degeneration